BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32309368)

  • 1. Identification of HO-1 as a novel biomarker for graft acute cellular rejection and prognosis prediction after liver transplantation.
    Jia J; Nie Y; Geng L; Li J; Liu J; Peng Y; Huang J; Xie H; Zhou L; Zheng SS
    Ann Transl Med; 2020 Mar; 8(5):221. PubMed ID: 32309368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of High-Mobility Group Box 1 (HMGB1) Expression as a Potential Predictor of Rejection and Poor Prognosis After Liver Transplantation.
    Ye Z; Jia J; Lv Z; Zheng S
    Ann Transplant; 2021 Jul; 26():e931625. PubMed ID: 34282108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme-oxygenase-1 expression correlates with severity of acute cellular rejection in lung transplantation.
    Bonnell MR; Visner GA; Zander DS; Mandalapu S; Kazemfar K; Spears L; Beaver TM
    J Am Coll Surg; 2004 Jun; 198(6):945-52. PubMed ID: 15194077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers in serum of acute cellular rejection after liver transplantation.
    Jiang Q; Ru Y; Yu Y; Li K; Jing Y; Wang J; Li G
    Transpl Immunol; 2019 Apr; 53():7-12. PubMed ID: 30472391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of peripheral CD154
    Boix F; Legaz I; Minhas A; Alfaro R; Jiménez-Coll V; Mrowiec A; Martínez-Banaclocha H; Galián JA; Botella C; Moya-Quiles MR; Sanchez-Bueno F; Robles R; de la Peña-Moral J; Ramirez P; Pons JA; Minguela A; Muro M
    Clin Exp Immunol; 2021 Feb; 203(2):315-328. PubMed ID: 33025622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.
    Zhang W; Yi Z; Keung KL; Shang H; Wei C; Cravedi P; Sun Z; Xi C; Woytovich C; Farouk S; Huang W; Banu K; Gallon L; Magee CN; Najafian N; Samaniego M; Djamali A; Alexander SI; Rosales IA; Smith RN; Xiang J; Lerut E; Kuypers D; Naesens M; O'Connell PJ; Colvin R; Menon MC; Murphy B
    J Am Soc Nephrol; 2019 Aug; 30(8):1481-1494. PubMed ID: 31278196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients.
    Gehrau R; Maluf D; Archer K; Stravitz R; Suh J; Le N; Mas V
    Mol Med; 2011; 17(7-8):824-33. PubMed ID: 21519635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-derived galectin-9 may be a novel predictor of rejection and prognosis after liver transplantation.
    Zhang AB; Peng YF; Jia JJ; Nie Y; Zhang SY; Xie HY; Zhou L; Zheng SS
    J Zhejiang Univ Sci B; 2019 Jul; 20(7):605-612. PubMed ID: 31168974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay.
    Massoud O; Heimbach J; Viker K; Krishnan A; Poterucha J; Sanchez W; Watt K; Wiesner R; Charlton M
    Liver Transpl; 2011 Jun; 17(6):723-32. PubMed ID: 21618694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HO-1/BMMSC perfusion using a normothermic machine perfusion system reduces the acute rejection of DCD liver transplantation by regulating NKT cell co-inhibitory receptors in rats.
    Cao H; Wu L; Tian X; Zheng W; Yuan M; Li X; Tian X; Wang Y; Song H; Shen Z
    Stem Cell Res Ther; 2021 Nov; 12(1):587. PubMed ID: 34819139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation.
    Asaoka T; Marubashi S; Kobayashi S; Hama N; Eguchi H; Takeda Y; Tanemura M; Wada H; Takemasa I; Takahashi H; Ruiz P; Doki Y; Mori M; Nagano H
    J Surg Res; 2012 Dec; 178(2):1003-14. PubMed ID: 22889476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Shaked A; Chang BL; Barnes MR; Sayre P; Li YR; Asare S; DesMarais M; Holmes MV; Guettouche T; Keating BJ
    Hepatology; 2017 Jan; 65(1):269-280. PubMed ID: 27533743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Hepatic Allograft Rejection in Pediatric Recipients: Independent Factors.
    Dehghani SM; Shahramian I; Afshari M; Bahmanyar M; Ataollahi M; Sargazi A
    Int J Organ Transplant Med; 2017; 8(4):203-206. PubMed ID: 29321836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
    Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood eosinophilia as a marker of acute cellular rejection in lung transplant recipients.
    Aguado Ibáñez S; Pérez Aguilar M; Royuela Vicente A; López García-Gallo C; Díaz Nuevo G; Salas Antón C; Ussetti Gil MP
    J Heart Lung Transplant; 2022 Apr; 41(4):501-507. PubMed ID: 35031205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of blood oxygen level-dependent magnetic resonance imaging to detect acute cellular rejection post-liver transplantation.
    Chiang HJ; Chou MC; Chuang YH; Li CW; Lin CC; Eng HL; Chen CL; Cheng YF
    Eur Radiol; 2022 Jul; 32(7):4547-4554. PubMed ID: 35247088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway.
    Ke B; Buelow R; Shen XD; Melinek J; Amersi F; Gao F; Ritter T; Volk HD; Busuttil RW; Kupiec-Weglinski JW
    Hum Gene Ther; 2002 Jul; 13(10):1189-99. PubMed ID: 12133272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.
    Bitetto D; Fabris C; Falleti E; Fornasiere E; Avellini C; Cmet S; Cussigh A; Fontanini E; Pirisi M; Corradini SG; Merli M; Molinaro A; Toniutto P
    Transplantation; 2012 May; 93(10):1038-44. PubMed ID: 22495472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation.
    Raschzok N; Reutzel-Selke A; Schmuck RB; Morgul MH; Gauger U; Prabowo KA; Tannus LM; Leder A; Struecker B; Boas-Knoop S; Bartels M; Jonas S; Lojewski C; Puhl G; Seehofer D; Bahra M; Pascher A; Pratschke J; Sauer IM
    Liver Transpl; 2015 Sep; 21(9):1195-207. PubMed ID: 25950774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients.
    Pérez-Carrillo L; Sánchez-Lázaro I; Triviño JC; Feijóo-Bandín S; Lago F; González-Juanatey JR; Martínez-Dolz L; Portolés M; Tarazón E; Roselló-Lletí E
    J Heart Lung Transplant; 2022 Feb; 41(2):137-147. PubMed ID: 34895840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.